862603-47-2

Upstream product

• 862603-45-0 (S)-5-methyl-3-(phenylthio)-3-(10-undecenyl)dihydrofuran-2(3H)-one 
• 862603-08-5 (R)-1-{(2S,5R,2'S,5'R)-5'-[(S)-1-(tert-Butyl-dimethyl-silanyloxy)-undecyl]-octahydro-[2,2']bifuranyl-5-yl}-but-3-en-1-ol 
• 158010-33-4 (S)-1-((2S,5R,2'S,5'R)-5'-Benzyloxymethyl-octahydro-[2,2']bifuranyl-5-yl)-undecan-1-ol 
• 862603-76-7 1-((2S,5R,2'S,5'R)-5'-Benzyloxymethyl-octahydro-[2,2']bifuranyl-5-yl)-undecan-1-ol 
• 158010-25-4 1-((2S,5R,2'S,5'R)-5'-Benzyloxymethyl-octahydro-[2,2']bifuranyl-5-yl)-undecan-1-one 
• 862603-26-7 (2S,5R,2'S,5'R)-5'-Benzyloxymethyl-octahydro-[2,2']bifuranyl-5-carbaldehyde 
• 170305-54-1 (2S,5R)-5-<(Benzyloxy)methyl>tetrahydrofuran-2-carboxaldehyde 
• 184435-75-4 (5S)-5-methyl-3-phenylsulfanyl-4,5-dihydrofuran-2(3H)-one 
• 7766-50-9 1-undecen-11-ylbromide 
• 112-29-8 1-bromo dodecane 
• 862603-02-9 Toluene-4-sulfonic acid (S)-3-{(2S,5R)-5-[(S)-1-(tert-butyl-dimethyl-silanyloxy)-undecyl]-tetrahydro-furan-2-yl}-3-[(E)-2-((S)-toluene-4-sulfinyl)-vinyloxy]-propyl ester 
• 862603-70-1 tert-Butyl-[(S)-1-((2R,5S)-5-{(S)-3-iodo-1-[(E)-2-((S)-toluene-4-sulfinyl)-vinyloxy]-propyl}-tetrahydro-furan-2-yl)-undecyloxy]-dimethyl-silane 
• 862603-04-1 tert-Butyl-dimethyl-{(S)-1-[(2S,5R,2'S,5'R)-5'-((S)-toluene-4-sulfinylmethyl)-octahydro-[2,2']bifuranyl-5-yl]-undecyloxy}-silane 
• 862603-00-7 Toluene-4-sulfonic acid (S)-3-{(2S,5R)-5-[(S)-1-(tert-butyl-dimethyl-silanyloxy)-undecyl]-tetrahydro-furan-2-yl}-3-hydroxy-propyl ester 

Downstream Products

• 862604-08-8 (S)-3-((R)-13-{(2S,5R,2'S,5'R)-5'-[(S)-1-(tert-Butyl-dimethyl-silanyloxy)-undecyl]-octahydro-[2,2']bifuranyl-5-yl}-13-hydroxy-tridecyl)-5-methyl-3-phenylsulfanyl-dihydro-furan-2-one 

Relevant academic research and scientific papers

Stereoselective syntheses of rolliniastatin 1, rollimembrin, and membranacin

A radical cyclization of β-alkoxyvinyl sulfoxides-Pummerer rearrangement-allylation protocol was successfully applied to the synthesis of the threol cis/threol cis/erythro bis-oxolane moiety in rolliniastatin 1 (1), rollimembrin (2), and membranacin (3).